VDI Laboratory Services, a specialty diagnostics clinical laboratory, provides advanced diagnostics for companion animals worldwide. With an ever expanding test menu the company is well known for its work in vitamin D metabolism, cancer, and GI disease. VDI's mission, "to provide the highest quality specialty diagnostic services and products for the advancement of care in companion animals". That guiding principle has led VDI to be the leading laboratory for Vitamin D, Cancer, and gastrointestinal testing. VDI now offers a wide array of wellness and acute care diagnostics worldwide. VDI invented Samplla, the worlds ONLY dry transport technology allowing veterinary clinics to send specimens cost-effectively due to its 3-week ambient stability. VDI has recently introduced the Advanced GI Panel - a 12+ blood biomarker panel - to diagnose a wide range of GI disorders (IBD, LSA, PLE, SIBO, malaborption, vitamin deficiency) in dogs and cats. Our new Complete Wellness Panel is a new 21 parameter panel that screens for a vast array of occult diseases including cancer and degenerative joint disease.VDI services are offered in the USA, Canada, South Korea, Germany, UK, Brazil, Paraguay, and Australia.www.vdilab.com

Glycominds has been a leading groundbreaker in microbiome biomarker research, offering the only validated serum biomarker tests on the market for Crohn's disease and ulcerative colitis. Developed in Glycominds laboratories studying thousands of patient samples in collaboration with global key opinion leaders, the proprietary IBDX technology platform takes the standard of glycan-based-marker systems to a new level. IBDX is routinely offered by LabCorp.www.ibdx.net

Veterinary Diagnostics Institute, inc was founded to develop innovative blood biomarkers for companion animal diagnostics. The company was founded around NT-proBNP, a cardiac marker for dogs, cats, and horses. The test called CardioCare was sold to Idexx and is now marketed as CardioPet.The next venture was into cancer using thymidine kinase, type 1 (TK1). Research and clinical studies developed a dual-biomarker blood panel using TK1 and an inflammatory protein (CRP in dogs, haptoglobin in cats) to improve sensitivity and specificity. The technology is now part of VDI Laboratory, LLC and is offered worldwide.